Qure.ai

New Study Published in Academic Radiology: AI-Driven Lung Nodule Detection with qXR    We’re pleased to share the findings of a study by Qure.ai, recently published in Academic Radiology. Conducted as part of our #regulatory submission to the #FDA for 510(k) clearance, this study evaluated the performance of our #lung nodule detection algorithm, qXR-LN.    The multi-reader, multi-case (MRMC) assessment involved chest X-rays (CXRs) from 40 different US hospitals and demonstrated an impressive sensitivity of 94%. Notably, the study highlighted the value of #AI as a second reader in significantly improving human detection of nodules:  • 46.4% reduction in missed nodules per reader (P < .001)  • No significant increase in false positives    These findings underscore the potential of AI in enabling #radiologists and non-radiology physicians to detect and localise #lungnodules with greater accuracy, reducing missed diagnoses and supporting earlier #lungcancer detection.    Why This Matters  Lung #cancer often first appears as non-calcified nodules on chest X-rays—the most widely used imaging modality in the diagnostic pathway. While CT remains the gold standard for detection, the accessibility of CXRs makes them critical in early lung cancer identification. This study demonstrates how AI can bridge the gap, enhancing detection rates and reducing diagnostic errors in routine clinical practice.    Aligned with Qure.ai’s mission, this study reinforces the transformative potential of AI-powered solutions to improve radiology workflows, reduce missed diagnoses, and enhance patient outcomes.    Read the full study here: https://lnkd.in/dAr4M-si Learn more about qXR-LN at our Radiological Society of North America (RSNA) 2024 Booth (4941): https://lnkd.in/dsinFeQv    #AIInHealthcare #LungCancerDetection #Radiology #FDAApproval #MedicalAI #PrecisionMedicine #RadiologyInnovation #AIInRadiology #RSNA #RSNA2024

Discover the interim findings from LungIMPACT, a clinical trial recognised by Nature Medicine as one of the “clinical trials to shape medicine in 2024.”    Join Dr. Nick Woznitza MBE, Consultant Radiographer (UCLH) and Clinical Academic (Canterbury Christ Church University), at Radiological Society of North America (RSNA) #RSNA2024 as he highlights how #AI, including Qure.ai’s #qXR, is reducing the time to critical diagnostics such as CT scans for chest X-rays suspicious of #lungcancer.    This session explores the transformative potential of #AIinlungcancer detection and its role in shaping evolving care pathways.    Session Details:  Title: Chest X-ray AI: Patients, Partners and Pathways  When: Tuesday, Dec 3, 2024  Time: 11:30–12:00 CST  Where: Booth #4941, South Hall    Stop by our booth at #RSNA to learn more about how Qure.ai is redefining #lung #cancer diagnostics with AI. #AIInHealthcare #LungCancerDetection #RadiologyInnovation 

Activating #healthcareAI is building momentum - from expanding #lungcancer surveillance to prioritizing patient cases and expediting emergency #strokecare.    Reaping the clinical, operational, and financial benefits of #AI requires carefully selecting a partner with proven results.    Qure.ai has 18 #FDA clearances, 60+ published evidence papers, and an AI deployment footprint in more than 90 countries.    Meet with us at the Radiological Society of North America (RSNA) 2024 Annual Meeting #RSNA2024 for discussion, debate, and demonstrations.    https://lnkd.in/dsinFeQv #RSNA

Join us at Radiological Society of North America (RSNA) #RSNA2024 for a session showcasing how #AI-powered collaborations are transforming #healthcare and making #earlydetection more impactful than ever.     Hear from Pelu Tran, Co-Founder and CEO of Ferrum Health, Inc., as he discusses how partnerships and advanced AI solutions are improving lives through early and accurate diagnosis.     When: Monday, Dec 2, 2024  Time: 13:30 – 14:00 CST  Where: Booth #4941, South Hall     Don’t miss this opportunity to see how #technology is reshaping patient outcomes, one diagnosis at a time.     #RSNA #AIInHealthcare #EarlyDetection #HealthcareInnovation 

Not long now! 🚀 Find out about #AI-powered #radiology for proven results at #RSNA2024 booth 4941 South Hall from the Qure.ai team.

Did you know? With 2 billion chest X-rays performed globally each year, many early signs of #lungcancer go unnoticed, hidden in plain sight. According to a recent The Imaging Wire article, it’s time to leverage #AI-enhanced chest X-rays (CXRs) to detect lung cancer early—even in patients undergoing routine checks for unrelated issues.     #AI makes #earlydetection more accessible, turning routine X-rays into life-saving diagnostics without requiring significant new investments.     Read the full article here - https://lnkd.in/dtwxYS4v    Heading to #RSNA2024 Radiological Society of North America (RSNA)? Let’s talk about how our qXR-LN solution is transforming chest X-rays with AI-powered precision. Visit us at Booth 4941 for a demo and explore how AI can help elevate patient care. #RSNA

Honored to be featured as contributors in the Digital Health Pharma Playbook by DayOne - Healthcare Innovation ! We’ve collaborated closely with DayOne to bring this playbook to life. It explores how #AI and #pharma can work together to drive #digitaltransformation in #healthcare, align objectives, overcome challenges, and foster #innovation.    A big thank you to DayOne for including Qure.ai in this valuable resource. We’re proud to contribute to a guide that offers in-depth strategies and real-world insights to help bridge the gap between pharma and #healthtech startups for a healthier future.    Download the playbook today to discover how #collaboration can spark innovation and create meaningful impact in #healthcare: https://lnkd.in/evdzFP4y #InnovateInBasel #DayOne #ShapingTheFutureOfHealthcare #AIInHealthcare #HealthTech #DigitalTransformation 

#ICYMI, a recent study announced at the World Conference on #LungCancer highlighted promising initial results using #AI-powered chest X-ray interpretation to detect #pulmonary nodules that could develop into early-stage lung cancers long before symptoms appear.    The retrospective study suggested that AI can detect lung nodules up to 3 years before lung #cancer symptoms or an actual diagnosis, using chest X-ray AI. https://lnkd.in/d3vRrDEG #LCAM #LCAM2024 #LungCancerAwarenessMonth

Another #AI activated! #qXR chest X-ray AI solution in partnership with the North East London Cancer Alliance and Sectra. By reducing chest X-ray wait times from weeks to just days, this #collaboration aims to transform #cancerdiagnostics across NHS Trusts, improving outcomes and empowering #healthcare teams.    Together, we’re driving efficiency, supporting the NHS workforce, and advancing #lunghealth. Excited for what’s ahead! #LCAM2024 #AIInHealthcare #HealthcareInnovation

This year, Qure.ai hosted its much-anticipated Goa Offsite, an all-company meeting that brought our #globalteam together—and it was nothing short of spectacular!    As Qure.ai celebrates significant milestones, with Qure.ai India achieving its third consecutive Great Place to Work® Institute (India) certification and Qure.ai UK (Great Place To Work UK) earning its first, we’re excited to share a few glimpses from our 2024 Goa Offsite, ‘Qureadise’. This event united Qure.ai to #innovate, reflect, and rejuvenate, with creativity, #collaboration, and connection taking center stage as we strengthened our bonds and continued to drive forward our shared vision.    From insightful discussions at our Town Hall to team-building activities, the event allowed us to reinforce the bonds that make Qure.ai a thriving and innovative place to work. It wasn’t just about work; it was about creating lasting memories and shared experiences that make our #global team stronger than ever.    What makes Qure.ai a Great Place to Work?  We’re not just solving #globalhealth challenges with #AI—we’re doing it with a team that values collaboration, personal growth, and a fun, inclusive culture.    #GreatPlaceToWork #TeamQure #WorkCulture #OfficeOffsite #AIInHealthcare #HealthInnovation